
Fertility Epigenetic Benchmarking Market Forecasts to 2032 – Global Analysis By Component (Products and Services), Technology (DNA Methylation, Histone Modification and RNA Sequencing), Application, End User and By Geography
Description
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Fertility Epigenetic Benchmarking Market, By Component
- 5.1 Introduction
- 5.2 Products
- 5.2.1 Kits and Reagents
- 5.2.2 Instruments and Accessories
- 5.3 Services
- 5.3.1 DNA Methylation Analysis
- 5.3.2 Histone Modification Analysis
- 5.3.3 Non-coding RNA Analysis
- 5.3.4 Chromatin Structure Analysis
- 6 Global Fertility Epigenetic Benchmarking Market, By Technology
- 6.1 Introduction
- 6.2 DNA Methylation
- 6.2.1 Bisulfite Sequencing
- 6.2.2 Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq)
- 6.2.3 Other DNA Methylation Technologies
- 6.3 Histone Modification
- 6.3.1 Chromatin Immunoprecipitation (ChIP)
- 6.3.2 Histone Methylation Analysis
- 6.3.3 Histone Acetylation Analysis
- 6.4 RNA Sequencing
- 7 Global Fertility Epigenetic Benchmarking Market, By Application
- 7.1 Introduction
- 7.2 Male Infertility
- 7.3 Female Infertility
- 7.4 Assisted Reproductive Technology (ART)
- 7.4.1 In Vitro Fertilization (IVF)
- 7.4.2 Intracytoplasmic Sperm Injection (ICSI)
- 7.4.3 Preimplantation Genetic Testing (PGT)
- 7.5 Predictive Diagnostics and Prognostics
- 8 Global Fertility Epigenetic Benchmarking Market, By End User
- 8.1 Introduction
- 8.2 Fertility Clinics and Hospitals
- 8.3 Academic and Research Institutes
- 8.4 Pharmaceutical and Biotechnology Companies
- 8.5 Diagnostic Laboratories
- 8.6 Contract Research Organizations (CROs)
- 9 Global Fertility Epigenetic Benchmarking Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
- 10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
- 11 Company Profiling
- 11.1 Illumina
- 11.2 Thermo Fisher Scientific
- 11.3 Merck KGaA
- 11.4 QIAGEN
- 11.5 F. Hoffmann-La Roche
- 11.6 PacBio
- 11.7 Danaher
- 11.8 Bio-Rad Laboratories
- 11.9 Promega
- 11.10 New England Biolabs
- 11.11 Zymo Research
- 11.12 Hologic
- 11.13 Active Motif
- 11.14 Chroma Medicine
- 11.15 CooperSurgical
- 11.16 Inherent Biosciences
- 11.17 Vitrolife
- 11.18 Ferring Pharmaceuticals
- List of Tables
- Table 1 Global Fertility Epigenetic Benchmarking Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Fertility Epigenetic Benchmarking Market Outlook, By Component (2024-2032) ($MN)
- Table 3 Global Fertility Epigenetic Benchmarking Market Outlook, By Products (2024-2032) ($MN)
- Table 4 Global Fertility Epigenetic Benchmarking Market Outlook, By Kits and Reagents (2024-2032) ($MN)
- Table 5 Global Fertility Epigenetic Benchmarking Market Outlook, By Instruments and Accessories (2024-2032) ($MN)
- Table 6 Global Fertility Epigenetic Benchmarking Market Outlook, By Services (2024-2032) ($MN)
- Table 7 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN)
- Table 8 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification Analysis (2024-2032) ($MN)
- Table 9 Global Fertility Epigenetic Benchmarking Market Outlook, By Non-coding RNA Analysis (2024-2032) ($MN)
- Table 10 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Structure Analysis (2024-2032) ($MN)
- Table 11 Global Fertility Epigenetic Benchmarking Market Outlook, By Technology (2024-2032) ($MN)
- Table 12 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation (2024-2032) ($MN)
- Table 13 Global Fertility Epigenetic Benchmarking Market Outlook, By Bisulfite Sequencing (2024-2032) ($MN)
- Table 14 Global Fertility Epigenetic Benchmarking Market Outlook, By Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq) (2024-2032) ($MN)
- Table 15 Global Fertility Epigenetic Benchmarking Market Outlook, By Other DNA Methylation Technologies (2024-2032) ($MN)
- Table 16 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification (2024-2032) ($MN)
- Table 17 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Immunoprecipitation (ChIP) (2024-2032) ($MN)
- Table 18 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Methylation Analysis (2024-2032) ($MN)
- Table 19 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Acetylation Analysis (2024-2032) ($MN)
- Table 20 Global Fertility Epigenetic Benchmarking Market Outlook, By RNA Sequencing (2024-2032) ($MN)
- Table 21 Global Fertility Epigenetic Benchmarking Market Outlook, By Application (2024-2032) ($MN)
- Table 22 Global Fertility Epigenetic Benchmarking Market Outlook, By Male Infertility (2024-2032) ($MN)
- Table 23 Global Fertility Epigenetic Benchmarking Market Outlook, By Female Infertility (2024-2032) ($MN)
- Table 24 Global Fertility Epigenetic Benchmarking Market Outlook, By Assisted Reproductive Technology (ART) (2024-2032) ($MN)
- Table 25 Global Fertility Epigenetic Benchmarking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
- Table 26 Global Fertility Epigenetic Benchmarking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
- Table 27 Global Fertility Epigenetic Benchmarking Market Outlook, By Preimplantation Genetic Testing (PGT) (2024-2032) ($MN)
- Table 28 Global Fertility Epigenetic Benchmarking Market Outlook, By Predictive Diagnostics and Prognostics (2024-2032) ($MN)
- Table 29 Global Fertility Epigenetic Benchmarking Market Outlook, By End User (2024-2032) ($MN)
- Table 30 Global Fertility Epigenetic Benchmarking Market Outlook, By Fertility Clinics and Hospitals (2024-2032) ($MN)
- Table 31 Global Fertility Epigenetic Benchmarking Market Outlook, By Academic and Research Institutes (2024-2032) ($MN)
- Table 32 Global Fertility Epigenetic Benchmarking Market Outlook, By Pharmaceutical and Biotechnology Companies (2024-2032) ($MN)
- Table 33 Global Fertility Epigenetic Benchmarking Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
- Table 34 Global Fertility Epigenetic Benchmarking Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Table of Contents
200 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.